Synthesis, characterization, and preclinical validation of a PET radiopharmaceutical for interrogating Aβ (β-amyloid) plaques in Alzheimer’s disease

Authors

Guruswami S.M. Sundaram, Washington University School of Medicine in St. Louis
Dhruva Dhavale, Washington University School of Medicine in St. Louis
Julie L. Prior, Washington University School of Medicine in St. Louis
Jothilingam Sivapackiam, Washington University School of Medicine in St. Louis
Richard Laforest, Washington University School of Medicine in St. Louis
Paul Kotzbauer, Washington University School of Medicine in St. Louis
Vijay Sharma, Washington University School of Medicine in St. Louis

Journal

EJNMMI Research

Publication Date

2015

Volume

5

Inclusive Pages

33

Document Type

Open Access Publication

DOI

10.1186/s13550-015-0112-4

Rights and Permissions

Sundaram et al. EJNMMI Research (2015) 5:33 DOI 10.1186/s13550-015-0112-4

Recommended Citation

Sundaram, Guruswami S.M.; Dhavale, Dhruva; Prior, Julie L.; Sivapackiam, Jothilingam; Laforest, Richard; Kotzbauer, Paul; and Sharma, Vijay, "Synthesis, characterization, and preclinical validation of a PET radiopharmaceutical for interrogating Aβ (β-amyloid) plaques in Alzheimer’s disease." EJNMMI Research. 5, 33. (2015).
https://digitalcommons.wustl.edu/open_access_pubs/3941